FT商學院

A new “miracle” weight-loss drug really works - raising huge questions
「減肥神藥」確實有效,但也面臨巨大爭議

Novo Nordisk’s Wegovy uses a hormone to regulate hunger. It’s wildly effective, but is it misguided?
諾和諾德的威戈維使用一種激素來調節飢餓感。它非常有效,但它有別的問題嗎?

In the summer of 2018, Lisa Robillard left her doctor’s office and walked down the long corridor of a medical complex in suburban Virginia. She’d just had an appointment with yet another physician who could only recommend “diet and exercise” when she brought up her life-long struggle with her weight. Robillard was 11 when she attended her first Weight Watchers meeting with her family, who celebrated hitting their dieting goals by going out for ice cream. Later, when her first fiancé proposed, the ring was conditional on dropping several dress sizes. She lost the weight but, when they split, it piled back on. Now, after 40 years of yo-yoing, she was dispirited.

2018年夏天,麗莎·羅畢拉德(Lisa Robillard)(Lisa Robillard)離開醫生的辦公室,走在維吉尼亞州郊區一家醫療中心的長廊上。在她與醫生的交談中,她提起了自己與體重的終生鬥爭,然而,像她之前的其他所有醫生一樣,這位醫生只能建議她「節食和鍛鍊」。羅畢拉德11歲時第一次和家人一起參加慧儷輕體(Weight Watchers)的減肥計劃,家人外出喫冰淇淋來慶祝實現了減肥目標。後來,當她的第一個未婚夫求婚時,帶上婚戒的條件是要降低幾個尺碼的衣服。她的體重減輕了,但當他們分手時,體重又增加了。如今,在斷斷續續了40年後,她已經不抱希望了。

您已閱讀3%(948字),剩餘97%(35004字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×